UnitedHealth is set to acquire Banmedica SA for $2.8bn

By Catherine Sturman
Share
In the US, it is clear to see that the merger of healthcare and healthcare insurance companies will continue to gain momentum in 2018, following on from...

In the US, it is clear to see that the merger of healthcare and healthcare insurance companies will continue to gain momentum in 2018, following on from the acquisition of Aetna by CVS Health in December last year.

It has been announced that UnitedHealth Group is set to acquire Chilean healthcare company Banmedica SA for $2.8bn in order to expand its current service offering and move into further global markets. The company is one of the largest healthcare companies across Latin America and also operates Brazil’s leading healthcare company, Amil.

The deal is expected to close in the first quarter of 2018, furthering UnitedHealth’s ambitions to grow internationally.

Related stories

The deal follows on from United Health’s acquisition of the DaVita Medical Group for $4.9bn, showcasing UnitedHealth’s aggressive growth strategy to not only offer exceptional healthcare insurance, but quality medical care to its patients, transforming the traditional roles both healthcare providers and insurance companies have previously offered.

“Combining with UnitedHealth Group will enable Empresas Banmédica to leverage UnitedHealth Group’s clinical expertise, advanced technology, and data and health information capabilities to better meet the health needs of people in Chile, Colombia and Peru,” both companies said in a statement.

“UnitedHealth Group will benefit from Empresas Banmédica’s substantial expertise in care delivery and health benefits across its three markets.”

Share

Featured Articles

NTT & Olympus: World's First Cloud Endoscopy System

NTT and medical technology company Olympus put on a demonstration, showing the IOWN APN's low-latency capability, for the first cloud endoscopy system

Richter BioLogics' New Biopharmaceutical GMP Facility

Richter BioLogics GmbH & Co KG's a new biopharmaceutical GMP facility in Germany will boost production capabilities and local employment

GE HealthCare's Pilot Study Shows Value of Portrait Mobile

A pilot study from GE Healthcare has shown the value of Portrait Mobile Continuous Monitoring Solution, a leap in post-surgical monitoring efficiency

50% of Teens to be Affected by Myopia Globally by 2050

Telehealth & COVID-19

NVIDIA’s AI Insights for Diabetes Prevention with GluFormer

Technology & AI

Novo Nordisk's CagriSema Next Gen Weight-Loss Treatment

Medical Devices & Pharma